For help on how to get the results you want, see our search tips.
64 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Orphan designations Remove Orphan designations filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (updated)
Date of authorisation: 08/05/2017,
, 
, 
, Revision: 7, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Raxone (updated)
Date of authorisation: 08/09/2015,, , , Revision: 5, Authorised, Last updated: 09/12/2019
-
List item
Human medicine European public assessment report (EPAR): Foclivia (updated)
Date of authorisation: 18/10/2009,, Revision: 9, Authorised, Last updated: 04/12/2019
-
List item
Human medicine European public assessment report (EPAR): Mepsevii (updated)
Date of authorisation: 23/08/2018,, , , Revision: 3, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Strensiq (updated)
Date of authorisation: 28/08/2015,, , , Revision: 10, Authorised, Last updated: 03/12/2019
-
List item
Human medicine European public assessment report (EPAR): Vyndaqel (updated)
Date of authorisation: 16/11/2011,, , , Revision: 15, Authorised, Last updated: 29/11/2019
-
List item
Human medicine European public assessment report (EPAR): Atriance (updated)
Date of authorisation: 22/08/2007,, , , Revision: 21, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Elaprase (updated)
Date of authorisation: 08/01/2007,, , , Revision: 19, Authorised, Last updated: 27/11/2019
-
List item
Human medicine European public assessment report (EPAR): Scenesse (updated)
Date of authorisation: 22/12/2014,, , , Revision: 5, Authorised, Last updated: 26/11/2019
-
List item
Human medicine European public assessment report (EPAR): Defitelio (updated)
Date of authorisation: 18/10/2013,, , , Revision: 10, Authorised, Last updated: 19/11/2019
-
List item
Human medicine European public assessment report (EPAR): Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
Date of authorisation: 10/10/2009,, Revision: 10, Authorised, Last updated: 06/11/2019
-
List item
Human medicine European public assessment report (EPAR): Orphacol
Date of authorisation: 12/09/2013,
Date of refusal: 25/05/2012,, , , Revision: 7, Authorised, Last updated: 16/10/2019
-
List item
Human medicine European public assessment report (EPAR): Firdapse (previously Zenas)
Date of authorisation: 23/12/2009,, , , Revision: 17, Authorised, Last updated: 13/09/2019
-
List item
Human medicine European public assessment report (EPAR): Imvanex
Date of authorisation: 31/07/2013,, , Revision: 14, Authorised, Last updated: 28/08/2019
-
List item
Human medicine European public assessment report (EPAR): Lojuxta
Date of authorisation: 31/07/2013,, , Revision: 11, Authorised, Last updated: 23/08/2019
-
List item
Human medicine European public assessment report (EPAR): Vedrop
Date of authorisation: 23/07/2009,, , Revision: 13, Authorised, Last updated: 22/08/2019
-
List item
Human medicine European public assessment report (EPAR): Naglazyme
Date of authorisation: 23/01/2006,, , , Revision: 14, Authorised, Last updated: 14/08/2019
-
List item
Human medicine European public assessment report (EPAR): ATryn
Date of authorisation: 28/07/2006,, , Revision: 16, Withdrawn, Last updated: 02/07/2019
-
List item
Human medicine European public assessment report (EPAR): Evoltra
Date of authorisation: 29/05/2006,, , Revision: 26, Authorised, Last updated: 08/05/2019
-
List item
Human medicine European public assessment report (EPAR): Myalepta
Date of authorisation: 29/07/2018,, , , Revision: 2, Authorised, Last updated: 25/04/2019
-
List item
Human medicine European public assessment report (EPAR): Brineura
Date of authorisation: 30/05/2017,, 
, , , Revision: 2, Authorised, Last updated: 24/01/2019
-
List item
Human medicine European public assessment report (EPAR): Pandemic Influenza Vaccine H5N1 Baxter AG
Date of authorisation: 16/10/2009,, Revision: 6, Authorised, Last updated: 18/01/2019
-
List item
Human medicine European public assessment report (EPAR): Lamzede
Date of authorisation: 23/03/2018,, , , Revision: 1, Authorised, Last updated: 05/12/2018
-
List item
Human medicine European public assessment report (EPAR): Ceplene
Date of authorisation: 07/10/2008,, , Revision: 12, Authorised, Last updated: 01/08/2018
-
List item
Human medicine European public assessment report (EPAR): Increlex
Date of authorisation: 02/08/2007,, , , Revision: 20, Authorised, Last updated: 24/11/2017